Wegovy vs Mounjaro: UK Clinical Comparison & Pricing
Does Wegovy Work As Well As Mounjaro for Weight Management?
When evaluating whether Wegovy works as well as Mounjaro, it's essential to understand their distinct mechanisms of action rather than making direct comparisons. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural satiety hormones, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. Both prescription-only medicines have demonstrated significant efficacy in clinical trials when used alongside a reduced-calorie diet and increased physical activity. The choice between them often depends on individual patient factors, tolerability, and practical considerations including cost and storage requirements.
Clinical evidence shows both medications can support substantial weight management outcomes, though they've been studied in different trial populations with varying endpoints. Wegovy's STEP programme demonstrated an average weight reduction of approximately 15% at 68 weeks, whilst Mounjaro's SURMOUNT trials showed similar impressive results with its dual-agonist approach. Your prescriber can help determine which option aligns best with your medical history, current medications, and weight management goals based on a comprehensive clinical assessment.
UK Pricing Comparison: Wegovy vs Mounjaro Cost Analysis
EverydayMeds offers transparent Wegovy pricing starting from £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers use code DOSE25 to access these competitive rates. Our bundle options provide convenience for longer-term treatment, including the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99, ensuring uninterrupted treatment progression. Every purchase includes clinical assessment, prescriber review, and temperature-controlled next-day delivery.
Compared to Mounjaro pricing across UK pharmacies, Wegovy often presents a more accessible entry point for patients beginning their weight management journey. Both medications require ongoing prescription oversight and regular clinical monitoring, making the total cost of treatment an important consideration for long-term success. EverydayMeds' comprehensive service model ensures you receive professional support throughout your treatment without unexpected additional charges for consultations or delivery services.
Clinical Evidence: How Does Wegovy Compare to Mounjaro Effectiveness?
The STEP clinical trial programme for Wegovy involved over 4,500 participants across multiple studies, with STEP 1 demonstrating the most comprehensive data for weight management in adults without diabetes. Participants experienced an average weight reduction of approximately 15% over 68 weeks when combining Wegovy with lifestyle modifications, as reported by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual-action mechanism in different patient populations, showing significant weight management outcomes with its combined GIP/GLP-1 approach. However, direct head-to-head comparisons between Wegovy and Mounjaro aren't available, as they've been studied in different trial designs with varying endpoints and participant characteristics. Both medications represent evidence-based approaches to weight management when prescribed appropriately alongside comprehensive lifestyle interventions.
Understanding How Wegovy Works Compared to Mounjaro Mechanisms
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally released by your intestine after eating. This mechanism helps slow gastric emptying, promoting feelings of fullness and satiety after smaller meals, whilst also working on brain appetite centres to potentially reduce food cravings. The once-weekly FlexTouch pen delivers a consistent dose of semaglutide, maintaining therapeutic levels throughout the week to support appetite regulation. Mounjaro's tirzepatide targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, creating a dual-action approach that may offer additional metabolic benefits. Both mechanisms require gradual dose escalation over 16-20 weeks to optimise tolerability and effectiveness whilst minimising potential gastrointestinal side effects.
Ordering Process: Does Wegovy vs Mounjaro Differ in UK Prescription Requirements?
Both Wegovy and Mounjaro require identical prescription protocols through EverydayMeds' GPhC-registered pharmacy (#9012878). The process begins with our 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and previous treatment experiences. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service) to determine appropriate treatment recommendations based on MHRA licensing criteria. Once approved, your medication ships via temperature-controlled next-day delivery to maintain cold-chain integrity throughout transit. The clinical assessment evaluates your suitability for either medication, ensuring you receive the most appropriate prescription-only medicine for your individual circumstances and medical profile.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Management
Wegovy offers a storage advantage over Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, making proper storage planning essential for treatment success. The FlexTouch pen system for Wegovy provides intuitive dose delivery with clear dosing windows and ergonomic design for self-administration. Dose escalation follows a structured 16-week schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), followed by 2.4mg maintenance dosing. This gradual progression helps optimise tolerability whilst allowing your body to adapt to the medication's appetite-suppressing effects.
Does Wegovy Work As Well As Mounjaro for Different Patient Populations?
Individual response to Wegovy versus Mounjaro can vary significantly based on genetic factors, medical history, concurrent medications, and adherence to lifestyle modifications. Some patients may respond more favourably to Wegovy's single GLP-1 action, whilst others might benefit from Mounjaro's dual-receptor approach, particularly those with concurrent metabolic conditions. Both medications require careful monitoring and potential dose adjustments based on clinical response and tolerability profiles. Your prescriber will evaluate factors including your BMI, weight-related comorbidities, previous weight management attempts, and current health status to recommend the most suitable option.
Cost considerations often influence treatment choice, with Wegovy's established pricing structure at EverydayMeds providing predictable monthly expenses for budgeting purposes. Both medications demonstrate similar contraindications and require equivalent clinical monitoring, making the choice primarily dependent on individual response patterns and practical factors including insurance coverage and out-of-pocket expenses. EverydayMeds' clinical team remains available throughout your treatment to discuss switching between options if your initial choice doesn't meet your expectations or tolerance requirements.
Secure Your Wegovy or Mounjaro Prescription Today
EverydayMeds provides both Wegovy and Mounjaro through our comprehensive weight management service, ensuring you receive expert guidance regardless of which medication suits your needs. New customers can immediately access our lowest prices using discount code FIRST40, whilst returning customers apply code DOSE25 at checkout for continued savings. Our GPhC-registered pharmacy (#9012878) maintains the highest standards for prescription-only medicine dispensing, with qualified prescribers available to discuss your treatment options during the assessment process. Begin your weight management journey today by visiting https://everydaymeds.co.uk/collections/wegovy to start your clinical assessment. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which option aligns best with your individual health profile and weight management objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
